Literature DB >> 16217391

Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia.

Shahrokh F Shariat1, Raheela Ashfaq, Claus G Roehrborn, Kevin M Slawin, Yair Lotan.   

Abstract

PURPOSE: We assessed the differential expression of survivin and other apoptotic markers in stromal and epithelial compartments of benign prostatic hyperplasia (BPH) and normal prostate tissue.
MATERIALS AND METHODS: Immunohistochemical staining for survivin, and transforming growth factor-beta1 and its receptors was done in normal prostate and BPH areas from 114 consecutive patients who underwent radical prostatectomy. Moreover, staining for survivin, Bcl-2, Bax, caspase-3 and Ki-67 was performed in prostate specimens from 23 consecutive patients who underwent open prostatectomy and 4 young patients who underwent cystoprostatectomy and had a normal prostate.
RESULTS: Survivin and Bcl-2 expression increased incrementally from normal prostate to epithelial BPH to stromal BPH. Caspase-3 expression was higher in BPH epithelium than in BPH stroma, which in turn was higher than that in normal prostate. Ki-67 was significantly over expressed in BPH stroma and epithelium. Survivin expression in BPH tissue correlated with International Prostate Symptom Score, quality of life, post-void residual urine volume, maximum urine flow rate and transforming growth factor-beta1 expression.
CONCLUSIONS: Survivin is over expressed in BPH and it correlates with BPH parameters. Increases in proliferation and inhibition of apoptosis have a role in BPH.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16217391     DOI: 10.1097/01.ju.0000176459.79180.d1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  23 in total

1.  Coordinated induction of cell survival signaling in the inflamed microenvironment of the prostate.

Authors:  David W McIlwain; Marloes Zoetemelk; Jason D Myers; Marshé T Edwards; Brandy M Snider; Travis J Jerde
Journal:  Prostate       Date:  2016-02-24       Impact factor: 4.104

2.  BCL-2 and BCL-XL expression are down-regulated in benign prostate hyperplasia nodules and not affected by finasteride and/or celecoxib.

Authors:  Feng Li; Laura E Pascal; Jianhua Zhou; Yibin Zhou; Ke Wang; Anil V Parwani; Rajiv Dhir; Peng Guo; Dalin He; Joel B Nelson; Zhou Wang
Journal:  Am J Clin Exp Urol       Date:  2018-02-05

3.  The role of combined measurement of tissue mRNA levels of AMACR and survivin in the diagnosis and risk stratification of patients with suspected prostate cancer.

Authors:  May Al-Maghrebi; Elijah O Kehinde; Jehoram T Anim; Mehraj Sheikh
Journal:  Int Urol Nephrol       Date:  2012-06-21       Impact factor: 2.370

4.  Diagnostic and prognostic value of bladder cancer-related transcript markers in urine.

Authors:  Juliane Schmidt; Catharina Propping; Woei-Yun Siow; Andrea Lohse-Fischer; Marieta Toma; Anka Baldauf-Twelker; Oliver W Hakenberg; Manfred P Wirth; Susanne Fuessel
Journal:  J Cancer Res Clin Oncol       Date:  2015-09-02       Impact factor: 4.553

Review 5.  Survivin: a promising biomarker for detection and prognosis of bladder cancer.

Authors:  Vitaly Margulis; Yair Lotan; Shahrokh F Shariat
Journal:  World J Urol       Date:  2007-10-26       Impact factor: 4.226

6.  BPH gene expression profile associated to prostate gland volume.

Authors:  Aurelien Descazeaud; Mark A Rubin; Matthias Hofer; Sunita Setlur; Nathalie Nikolaief; Francis Vacherot; Pascale Soyeux; Laurence Kheuang; Claude C Abbou; Yves Allory; Alexandre de la Taille
Journal:  Diagn Mol Pathol       Date:  2008-12

Review 7.  [Pathophysiology and therapy of benign prostatic hyperplasia].

Authors:  Natalie Sampson; Stephan Madersbacher; Peter Berger
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

8.  Inflammatory Mechanisms Associated with Prostatic Inflammation and Lower Urinary Tract Symptoms.

Authors:  Jennifer L St Sauver; Steven J Jacobsen
Journal:  Curr Prostate Rep       Date:  2008-05-01

9.  Leptin regulates proliferation and apoptosis in human prostate.

Authors:  Eduardo Leze; Jorge Luiz Alves-Pereira; Sicilia Colli; Fernanda Silveira Cavalcante; Francisco José Sampaio; Cristiane da Fonte Ramos
Journal:  ScientificWorldJournal       Date:  2012-05-02

10.  Role of IAPs in prostate cancer progression: immunohistochemical study in normal and pathological (benign hyperplastic, prostatic intraepithelial neoplasia and cancer) human prostate.

Authors:  Gonzalo Rodríguez-Berriguete; Benito Fraile; Fermín R de Bethencourt; Angela Prieto-Folgado; Nahikari Bartolome; Claudia Nuñez; Bruna Prati; Pilar Martínez-Onsurbe; Gabriel Olmedilla; Ricardo Paniagua; Mar Royuela
Journal:  BMC Cancer       Date:  2010-01-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.